Lin Patrick has filed 24 insider transactions across 1 company since January 2024.
Most recent transaction: a purchase of 1603 shares of Processa Pharmaceuticals, Inc. ($PCSA) on March 31, 2026.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | P | Common Stock | 1603 | $2.54 | 5,096.0000 | 56,644,223 | 45.89% | 0.00% |
| Jan. 1, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | M | Common Stock | 193 | $0.00 | 0.0000 | 56,644,223 | 100.00% | 0.00% |
| Jan. 1, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | M | Common Stock | 193 | $0.00 | 3,493.0000 | 56,644,223 | 5.85% | 0.00% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Restricted Stock Units | 68000 | $0.00 | 68,000.0000 | 5,269,240 | 9999.99% | 1.29% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Stock Options (Right to Buy) | 204000 | $0.00 | 204,000.0000 | 5,269,240 | 9999.99% | 3.87% |
| July 24, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Restricted Stock Units | 1401650 | $0.00 | 1,412,082.0000 | 5,269,240 | 9999.99% | 26.60% |
| April 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | F | Common Stock | 4814 | $0.41 | 82,227.0000 | 5,269,240 | 5.53% | 0.09% |
| April 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | M | Common Stock | 14482 | $0.00 | 87,041.0000 | 5,269,240 | 19.96% | 0.27% |
| Jan. 29, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Warrants | 43500 | $0.00 | 43,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Warrants | 21750 | $0.00 | 21,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | P | Common Stock | 43500 | $0.80 | 72,559.0000 | 0 | 149.70% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | M | Common Stock | 644 | $0.00 | 29,330.0000 | 0 | 2.24% | 0.00% |
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | F | Common Stock | 539 | $2.79 | 28,686.0000 | 0 | 1.84% | 0.00% |
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | M | Common Stock | 1675 | $0.00 | 29,225.0000 | 0 | 6.08% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | F | Common Stock | 271 | $1.71 | 29,059.0000 | 0 | 0.92% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Restricted Stock Units | 2713 | $0.00 | 22,201.0000 | 0 | 13.92% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Restricted Stock Units | 2035 | $0.00 | 24,236.0000 | 0 | 9.17% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Restricted Stock Units | 339 | $0.00 | 24,575.0000 | 0 | 1.40% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | A | Restricted Stock Units | 339 | $0.00 | 24,914.0000 | 0 | 1.38% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | M | Restricted Stock Units | 1675 | $0.00 | 20,132.0000 | 0 | 7.68% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | F | Common Stock | 539 | $2.79 | 28,614.0000 | 0 | 1.85% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | M | Common Stock | 1675 | $0.00 | 29,153.0000 | 0 | 6.10% | 0.00% |
| Feb. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | P | Common Stock | 1500 | $2.40 | 27,478.0000 | 0 | 5.77% | 0.00% |
| Jan. 31, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Lin Patrick | Chief Business - Strategy Off | P | Common Stock | 2500 | $2.37 | 25,978.0000 | 0 | 10.65% | 0.00% |